ConductScience.org, home

Paper40692147

Machine Learning, Virtual Screening and Bioactivity Evaluation to Identify AJ-292/12941271 as an Anti-proliferative Agent and Target mTOR Protein.

Li M and 6 others. Curr Med Chem, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Machine Learning, Virtual Screening and Bioactivity Evaluation to Identify AJ-292/12941271 as an Anti-proliferative Agent and Target mTOR Protein. Papers, record 40692147. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40692147

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Machine Learning, Virtual Screening and Bioactivity Evaluation to Identify AJ-292/12941271 as an Anti-proliferative Agent and Target mTOR Protein.
PubMed
Journal
Curr Med Chem
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-10-07
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Li MMin
2Yang YYang
3Wang RRan
4Zhu WWufu
5Tu YYuanbiao
6Zheng PPengwu
7Wang LLinXiao

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
TOR Serine-Threonine KinasesMajor topic
Antineoplastic AgentsMajor topic
Machine LearningMajor topic
MTOR InhibitorsMajor topic
Protein Kinase InhibitorsMajor topic
Humans
Cell Proliferation
Drug Screening Assays, Antitumor
Structure-Activity Relationship
Molecular Docking Simulation
Cell Line, Tumor
Molecular Structure

Source PubMed

Download CSV of topics

References37

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
138572751Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin2024https://conductscience.org/library/papers/38572751PubMed
236097292Isoform-resolved mRNA profiling of ribosome load defines interplay of HIF and mTOR dysregulation in kidney cancer.Nat Struct Mol Biol2022https://conductscience.org/library/papers/36097292PubMed
336010585PI3K/AKT/mTOR-Targeted Therapy for Breast Cancer.Cells2022https://conductscience.org/library/papers/36010585PubMed
434279440Targeting the PI3K/AKT/mTOR Signaling Pathway in Lung Cancer: An Update Regarding Potential Drugs and Natural Products.Molecules2021https://conductscience.org/library/papers/34279440PubMed
524782981Targeting PI3K/Akt/mTOR Signaling in Cancer.Front Oncol2014https://conductscience.org/library/papers/24782981PubMed
632175074mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges.Cell Biosci2020https://conductscience.org/library/papers/32175074PubMed
736442772
mTOR inhibitor, gemcitabine and PD-L1 antibody blockade combination therapy suppresses pancreatic cancer progression via metabolic reprogramming and immune microenvironment remodeling in Trp53flox/+LSL-KrasG12D/+Pdx-1-Cre murine models.
Cancer Lett2023https://conductscience.org/library/papers/36442772PubMed
825524385mTOR signaling, Tregs and immune modulation.Immunotherapy2014https://conductscience.org/library/papers/25524385PubMed
931408724mTOR: Role in cancer, metastasis and drug resistance.Semin Cancer Biol2019https://conductscience.org/library/papers/31408724PubMed
1017545512The mammalian target of rapamycin signaling pathway: twists and turns in the road to cancer therapy.Clin Cancer Res2007https://conductscience.org/library/papers/17545512PubMed
1129523752Drug discovery targeting the mTOR pathway.Clin Sci (Lond)2018https://conductscience.org/library/papers/29523752PubMed
1232416459Targeting mTOR for fighting diseases: A revisited review of mTOR inhibitors.Eur J Med Chem2020https://conductscience.org/library/papers/32416459PubMed
1323983265Integration of mTOR and estrogen-ERK2 signaling in lymphangioleiomyomatosis pathogenesis.Proc Natl Acad Sci U S A2013https://conductscience.org/library/papers/23983265PubMed
1426810941New perspectives on mTOR inhibitors (rapamycin, rapalogs and TORKinibs) in transplantation.Br J Clin Pharmacol2016https://conductscience.org/library/papers/26810941PubMed
1522844270Pathophysiological insights into cardiovascular health in metabolic syndrome.Exp Diabetes Res2012https://conductscience.org/library/papers/22844270PubMed
1636182721Sarcoidosis incidence after mTOR inhibitor treatment.Semin Arthritis Rheum2022https://conductscience.org/library/papers/36182721PubMed
1729229111Toxicity risk from glucocorticoids in sarcoidosis patients.Respir Med2017https://conductscience.org/library/papers/29229111PubMed
1835688004Contemporary mTOR inhibitor scaffolds to diseases breakdown: A patent review (2015-2021).Eur J Med Chem2022https://conductscience.org/library/papers/35688004PubMed
1930359003
Discovery and Preclinical Characterization of 5-[4,6-Bis({3-oxa-8-azabicyclo[3.2.1]octan-8-yl})-1,3,5-triazin-2-yl]-4-(difluoromethyl)pyridin-2-amine (PQR620), a Highly Potent and Selective mTORC1/2 Inhibitor for Cancer and Neurological Disorders.
J Med Chem2018https://conductscience.org/library/papers/30359003PubMed
2035164788m6A modification: recent advances, anticancer targeted drug discovery and beyond.Mol Cancer2022https://conductscience.org/library/papers/35164788PubMed

See all 37 referencesDownload CSV of references

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
MTOR2475PubTator's text mininghttps://conductscience.org/library/genes/2475NCBI Gene
PIK3CB5291PubTator's text mininghttps://conductscience.org/library/genes/5291NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40692147

GET https://conductscience.org/api/papers/v1/40692147/references?page=2